Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.
Other companies in Nektar Therapeutics’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phathom Pharmaceuticals Inc (NASDAQ:PHAT) and Alumis Inc (NASDAQ:ALMS).
Nektar Therapeutics has a consensus price target of $52.36.
The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $58.8 last updated December 15, 2025 at 7:59 PM EST.
There are no upcoming dividends for Nektar Therapeutics.
Nektar Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Nektar Therapeutics.
Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.